News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Smith Thomas B
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
4
| Smith Thomas B (EVP and Chief Medical Officer) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 31,185 shares
@ $0 |
|
| 03/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Smith Thomas B (Chief Medical Officer) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 259,186 options to buy
@ $3.66, valued at
$948.6k
Granted 46,448 restricted stock units
@ $0
Exercised 17,361 restricted stock units
@ $0
Exercised 7,548 restricted stock units
@ $0
Exercised 7,667 restricted stock units
@ $0 |
|
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Smith Thomas B (Chief Medical Officer) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Sold 2,927 shares
@ $5.38, valued at
$15.7k
Exercised 7,666 restricted stock units
@ $0 |
|
| 01/31/2020 |
4
| Smith Thomas B (Chief Medical Officer) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 110,122 options to buy
@ $0
Granted 22,645 restricted stock units
@ $0 |
|
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2018 |
4
| Smith Thomas B (Chief Medical Officer) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 117,691 options to buy
@ $0 |
|
|
|